Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By

Savaysa (edoxaban) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and blood clots that travel to other parts of the body in people with nonvalvular atrial fibrillation (NVAF), a type of irregular heartbeat.

How Savaysa Works and How It’s Taken

Savaysa is a blood thinner called a factor Xa inhibitor. It blocks factor Xa, a protein that helps blood clot. This reduces the production of thrombin, another protein involved in clotting, and helps prevent blood clots from forming.

Doctors prescribe Savaysa when:

  • A person with nonvalvular atrial fibrillation needs to reduce the risk of stroke and systemic embolism (a blood clot that travels to another part of the body).
  • A person needs treatment for deep vein thrombosis, a blood clot in a deep vein, usually in the leg, after five to 10 days of treatment with an injectable blood thinner.
  • A person needs treatment for pulmonary embolism, a blood clot in the lungs, after five to 10 days of treatment with an injectable blood thinner.

Savaysa is taken by mouth, with or without food. If you have trouble swallowing tablets, talk to your healthcare provider about other ways to take Savaysa.

Typical Dosing for Nonvalvular Atrial Fibrillation

Creatinine clearance is a measure of how well the kidneys filter waste from the blood.

  • 60 milligrams once daily — For people with creatinine clearance greater than 50 and up to 95 milliliters per minute.
  • 30 milligrams once daily — For people with creatinine clearance of 15 to 50 milliliters per minute.
  • Do not use Savaysa — For people with creatinine clearance greater than 95 milliliters per minute because of an increased risk of stroke caused by a blood clot compared with warfarin.

This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.

Typical Dosing for Deep Vein Thrombosis and Pulmonary Embolism

  • 60 milligrams once daily — The recommended dose after five to 10 days of treatment with an injectable blood thinner.
  • 30 milligrams once daily — For people who have any of the following:
    • Creatinine clearance of 15 to 50 milliliters per minute
    • Body weight of 60 kilograms or less
    • Use of certain medicines called P-gp inhibitors that can affect how Savaysa works

This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.

Back to top

Savaysa Side Effects

In clinical studies of Savaysa, the most common side effects occurred in about 2 percent to 26 percent of people. These included:

  • Bleeding (such as nosebleeds, bleeding from the stomach or intestines, or blood in the urine)
  • Rash
  • Abnormal liver function tests (changes in liver-related blood test results)
  • Anemia (low red blood cell count)

Serious Side Effects and Warnings

Savaysa has a boxed warning, the FDA’s strongest safety warning, for some of the serious risks described below. A boxed warning does not mean the drug is unsafe for everyone or that everyone faces the same level of risk.

Savaysa can cause serious side effects that may require immediate medical attention. These include:

  • Increased risk of ischemic stroke with very good kidney function — In people with nonvalvular atrial fibrillation and creatinine clearance greater than 95 milliliters per minute, Savaysa should not be used because it may raise the risk of ischemic stroke.
  • Increased risk of stroke after stopping Savaysa too soon — Stopping an anticoagulant without another blood thinner can raise the risk of stroke.
  • Spinal or epidural hematoma — Bleeding around the spine can cause long-term or permanent paralysis, especially with spinal procedures or certain types of anesthesia.
  • Serious bleeding — Bleeding can be severe or life-threatening.
  • Mechanical heart valves or moderate to severe mitral stenosis — Savaysa is not recommended for people with mechanical heart valves or moderate to severe narrowing of the mitral valve, a valve in the heart.
  • Increased risk of blood clots in people with triple-positive antiphospholipid syndrome (APS) — Blood thinners like Savaysa have been linked to a higher risk of recurrent blood clots compared with vitamin K antagonists, such as warfarin.
  • Allergic reactions — These include angioedema, which can cause swelling of the face, lips, tongue, or throat.

Get medical help right away if you think you are having a serious reaction.

This drug has a boxed warning, the FDA's strongest safety warning, for some of the serious risks mentioned above. A boxed warning does not mean the drug is unsafe for everyone or that everyone faces the same level of risk.

Back to top

If you experience serious side effects, you can report them to the FDA online or by calling 1-800-FDA-1088. You can also contact the drug's manufacturer.

Back to top

How to Save on Savaysa

Daiichi Sankyo, the manufacturer of Savaysa, offers the SAVAYSA Savings Card. Eligible people with commercial or employer-sponsored insurance may qualify for copay assistance and pay as little as $4 per month, depending on eligibility and program terms.

To learn more, visit the Savaysa savings page.

Back to top

What To Know Before Taking Savaysa

Before starting Savaysa for nonvalvular atrial fibrillation, your doctor will check your kidney function using a test called creatinine clearance.

Before taking Savaysa, tell your doctor if you have any allergies to edoxaban or any ingredients in Savaysa.

Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.

Also tell your doctor if you:

  • Have liver or kidney problems.
  • Have ever had bleeding problems.
  • Have a mechanical heart valve.
  • Have antiphospholipid syndrome (APS), a condition that increases the risk of blood clots.
  • Have cancer of the stomach or intestines (gastrointestinal cancer).

Do not take Savaysa if you have active abnormal bleeding. Savaysa can increase the risk of serious bleeding.

If you miss a dose, take it as soon as you remember on the same day. Take your next dose at the usual time the following day. Do not take two doses at the same time to make up for a missed dose.

If you are pregnant or planning to become pregnant while taking Savaysa, talk with your doctor about the risks and benefits. It is not known whether Savaysa can harm a developing baby. Tell your doctor right away if you become pregnant during treatment.

If you can become pregnant, discuss pregnancy planning and the risk of severe uterine bleeding with your doctor.

If you are breastfeeding or planning to breastfeed, talk with your doctor before taking Savaysa. Do not breastfeed while taking Savaysa. It is not known whether Savaysa passes into breast milk.

Back to top

Community FAQs

These answers are fact-checked by our editorial staff.

How effective is Savaysa for heart conditions?

In a large clinical study, Savaysa was compared with warfarin, another blood thinner, in people with nonvalvular atrial fibrillation. Among people whose creatinine clearance was 95 milliliters per minute or less:

  • Stroke or systemic embolism (a blood clot that travels to another part of the body) — Occurred at a rate of 1.2 percent per year with Savaysa and 1.8 percent per year with warfarin.
  • Ischemic stroke (caused by a blocked blood vessel) — Occurred at a rate of 0.9 percent per year with Savaysa and 1.1 percent per year with warfarin.
  • Hemorrhagic stroke (caused by bleeding in the brain) — Occurred at a rate of 0.3 percent per year with Savaysa and 0.6 percent per year with warfarin.

These results were from the Savaysa 60-milligram treatment group, including people whose dose was reduced to 30 milligrams when needed. Savaysa should not be used to reduce stroke risk in people with NVAF whose creatinine clearance is greater than 95 milliliters per minute because they had a higher risk of ischemic stroke than those taking warfarin.

How long does Savaysa take to work for heart conditions?

Savaysa begins affecting blood clotting after it is taken by mouth. Its strongest effects on blood clotting and highest blood levels are generally reached within one to two hours. With once-daily dosing, Savaysa reaches steady blood levels within three days.

These findings describe how quickly Savaysa acts in the body. They do not establish an exact time when protection against stroke begins.

Does Savaysa interact with other medicines?

Yes. Savaysa can interact with certain medicines, which may increase your risk of bleeding or affect how well Savaysa works. These include:

  • Other blood thinners — Medicines such as warfarin and heparin can increase the risk of bleeding.
  • Aspirin and other antiplatelet medicines — These medicines help prevent blood clots but can increase bleeding risk when taken with Savaysa.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) — Medicines such as ibuprofen and naproxen, especially with long-term use, can increase bleeding risk.
  • Certain antidepressants — Medicines such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may increase bleeding risk.
  • Rifampin — This antibiotic should not be taken with Savaysa because it can affect how the medicine works.
  • Certain P-gp inhibitors — These medicines affect how Savaysa moves through the body. Some may require a lower Savaysa dose when treating deep vein thrombosis or pulmonary embolism.

Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements you take. Do not start or stop any medicines without talking to your healthcare provider.

Back to top

Thank you for subscribing!

Become a member to get even more